The Radio Awards honours outstanding achievements across Campus, Community, Public Broadcast, and Commercial radio, setting benchmarks for all stations and professionals to strive towards. Finalists for the general categories have been announced.
Adidas Originals and the Lego Group have collaborated yet again, and are presenting a new take on the classic Superstar silhouette. Launching alongside the playful Adidas Originals Lego Superstar sneaker is a buildable Superstar Lego brick model.
Katlego Letsoalo is a rising talent in the South African mining industry, and he would like to see is more young people playing a role in the future direction of the sector. He is currently the monitoring and evaluation specialist with the Minerals Council South Africa,ByNicci Botha
There is currently no established cure for Ebola – could antibody treatments be the answer? AHMED JALLANZO/EPA
Antibodies, which are special defence proteins made by our body in response to infection or vaccination, are one of the treatments that were investigated. Once the best antibodies for fighting a disease have been identified, they can be made in bulk and used as a treatment.
In all, 82 antibodies were derived from the blood cells of eleven people given the vaccine. These were combined into three separate groups, with each group containing three or four antibodies with different properties. One combination of antibodies successfully cured all six animals infected with the Ebola virus when it was administered three days after the start of the infection.
Perfect combination of antibodies
Vaccines can have side effects, so for people with immune system disorders, older people and pregnant women, antibodies are a safer form of treatment. Antibodies can be isolated from human blood by selecting individual B cells – the specialised immune cells that secrete antibodies. The genetic code for making an antibody is inside the B cells, which is extracted using advanced molecular techniques. Once this code is known, huge quantities of the antibody can be made in a lab.
Antibodies attach to viruses and prevent them from entering cells. Each antibody has different properties, such as how and where it binds to the virus and if it can block the virus from infecting the cells. These properties were examined for the 82 antibodies.
The antibodies isolated in this study from vaccinated donors had the same characteristics as antibodies isolated from immunised animals and people who have survived Ebola. Those Ebola antibodies are already well-studied and available for clinical trials in humans.
There is an advantage for developing antibody treatments from healthy people who have been vaccinated – it resolves the difficult issue of handling unscreened blood samples from human survivors in remote areas, where donors may potentially harbour Ebola or other infectious viruses such as hepatitis B or HIV.
The antibody mix from this study is also being studied for protection against the two other species of the Ebola virus – Sudan and Bundibugyo. These have caused significant outbreaks in the past.
Even if the particular combination of antibodies fails to treat these viruses, all is not lost. Antibodies from this study, combined with antibodies from other research groups which react to all species may provide a better treatment. Antibodies are also useful tools for studying the Ebola virus and human immune responses towards it. By tracking how antibodies attack cells, it’s possible to identify the vulnerable parts of the virus.
This study shows that a human vaccine trial is a golden opportunity to isolate antibodies that can effectively be used as a treatment. This may be important for tackling emerging infections like bird flu, MERS, SARS and Chikungunya viruses, for which we have no established drugs or therapeutic antibodies.
The Conversation Africa The Conversation Africa is an independent source of news and views from the academic and research community. Its aim is to promote better understanding of current affairs and complex issues, and allow for a better quality of public discourse and conversation. Go to: https://theconversation.com/africa
LEGAL DISCLAIMER: This Message Board accepts no liability of legal consequences that arise from the Message Boards (e.g. defamation, slander, or other such crimes). All posted messages are the sole property of their respective authors. The maintainer does retain the right to remove any message posts for whatever reasons. People that post messages to this forum are not to libel/slander nor in any other way depict a company, entity, individual(s), or service in a false light; should they do so, the legal consequences are theirs alone. Bizcommunity.com will disclose authors' IP addresses to authorities if compelled to do so by a court of law.